TNF and Crohn disease: From a therapeutic point of view, it is important to mention that Latent-CST showed similar protective actions in chronic colitis to those previously reported for a stable cortistatin analogue, which displayed therapeutic efficiencies that are comparable to those observed for treatments of reference in the clinical management of patients with Crohn’s disease, such as anti-TNFα antibodies or mesalazine [23].